Fennec Pharmaceuticals
FENC
27 hedge funds and large institutions have $40.7M invested in Fennec Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 9 closing their positions.
13% more capital invested
Capital invested by funds: $36M → $40.7M (+$4.77M)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
2.63% less ownership
Funds ownership: 45.17% → 42.54% (-2.6%)
10% less funds holding
Funds holding: 30 → 27 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Northern Trust
Chicago,
Illinois
| – | -$388K | -96,972 | Closed |
|
27
Millennium Management
New York
| – | -$191K | -47,634 | Closed |
|
28
Bank of America
Charlotte,
North Carolina
| – | -$36K | -9,098 | Closed |
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$11K | -2,810 | Closed |
|
30
Legal & General Group
London,
United Kingdom
| – | -$7K | -1,681 | Closed |
|
31
Wells Fargo
San Francisco,
California
| – | -$4K | -1,074 | Closed |
|
32
Barclays
London,
United Kingdom
| – | -$2K | -543 | Closed |
|
33
Morgan Stanley
New York
| – | -$622 | -141 | -99% |
|
34
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$349 | -79 | -81% |
|
35
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$71 | -16 | -11% |
|
36
Simplex Trading
Chicago,
Illinois
| – | +$441 | +100 | New |
|
FENC Hedge Fund Activity: Q3 2019 in Review
27 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q3 2019, worth a combined $40.7M — up 13% from $36M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of FENC and 6 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Solas Capital Management, adding an estimated $411K. The largest seller was Opaleye Management, exiting entirely with an estimated $1.18M sold.
- 27 institutional investors held Fennec Pharmaceuticals (FENC) as of Q3 2019, down from 30 in Q2 2019.
- Funds reported $40.7M of Fennec Pharmaceuticals stock for Q3 2019, up 13% quarter-over-quarter.
- 6 funds opened new Fennec Pharmaceuticals positions in Q3 2019 and 9 closed out, a net change of -3 holders.
- The largest Fennec Pharmaceuticals buyer in Q3 2019 was Solas Capital Management, an estimated $411K added.
- The largest Fennec Pharmaceuticals seller in Q3 2019 was Opaleye Management, an estimated $1.18M sold.
Based on aggregated 13F filings for Q3 2019.